Spin-off from the Pasteur Institute, DIACCURATE is a late preclinical stage biotechnology company which develops “sole-in-class” therapeutics in oncology and immunotherapy.
Location: France, Ile-de-France, Paris
Founded date: 2014
Investors 1
Date | Name | Website |
- | Truffle Ca... | truffle.co... |
Mentions in press and media 2
Date | Title | Description | Category | Author | Source |
08.09.2021 | DIACCURATE... | DGAP-News: DIACCURATE SAS / Ke... | - | - | marketscre... |
12.01.2021 | DIACCURATE... | BIOKINESIS absorption by DIACC... | - | - | marketscre... |